Ketoacidosis with euglycemia in a patient with type 2 diabetes mellitus taking dapagliflozin: A case report

RATIONALE: Dapagliflozin (a sodium-glucose cotransporter-2 [SGLT2] inhibitor) represents the most recently approved class of oral medications for the treatment of type 2 diabetes. Dapagliflozin lowers plasma glucose concentration by inhibiting the renal reuptake of glucose in the proximal renal tubu...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Medicine (Baltimore)
Main Authors: Yeo, Sang Mok, Park, Hayeon, Paek, Jin Hyuk, Park, Woo Yeong, Han, Seungyeup, Park, Sung Bae, Jin, Kyubok
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2019
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6370067/
https://ncbi.nlm.nih.gov/pubmed/30653152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000014150
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker